Compound

D0012 | Atractyloside

Molecular Formula C30H44K2O16S2
Molecular Weight 803
Structure
Description natural toxic glycoside; ADP/ATP translocase inhibitor

Organism Test type Route Dose (normalized dose) Effect Source
rat LD50 intraperitoneal 143mg/kg (143mg/kg) Archives of Toxicology. Vol. 32, Pg. 169, 1974.
rat LD50 intramuscular 431mg/kg (431mg/kg) Bolletino della Societe Italiana di Biologia Sperimentale. Vol. 44, Pg. 253, 1968.


  • 15-Hydroxy-2-((2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-beta-D-glucopyranosyl)oxy)-19-norkaur-16-en-18-oic acid dipotassium salt, (2beta,4alpha,15alpha)- 17754-44-8 19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-((2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-beta-D-glucopyranosyl)oxy)-, (2beta,4alpha,15alpha)-
    19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-((2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-beta-D-glucopyranosyl)oxy)-, dipotassium salt, (2beta,4alpha,15alpha)- Atractylate de potassium Atractylate de potassium [French]
    Atractylin (C30 glucoside) Attrattiloside Attrattiloside [Italian]
    C09064 CHEBI:2913 Dipotassium hydrogen 15alpha-hydroxy-2beta-((2-O-isovaleryl-3,4alpha-di-O-sulphonato-beta-D-glucopyranosyl)oxy)-19-norkaur-16-en-18-oate
    EINECS 241-744-8 H6WC6L09RM Potassium atractylate
    Q27105880 UNII-H6WC6L09RM atractyloside
    atractyloside, potassium salt

    DrugBank Name Atractylodes lancea root oil
    CAS Number 17754-44-8
    PubChem Compound 442004
    KEGG Compound ID C09064
    ChEBI 2913
    ChemSpider 390563

    1. Stewart et al. (2000)